New York, USA - June 25, 2025 - CD BioSciences, the leading provider of innovative services and solutions in life sciences, announced multi-omics analysis services to expedite aging research. Using different omics technologies including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, CD BioSciences offers a broad scope of coverage into the biology of aging.
"Systems biology is needed to understand the molecular basis of aging," stated the business development manager of CD BioSciences. "Our multi-omics analysis service allows researchers to discover challenging insights into longevity, cellular senescence, and age-associated diseases, greatly expedite the process of anti-aging intervention."
Why do omics studies matter in aging research?
Recent advances in high-throughput technologies have enabled omics studies, opening new pathways to understanding the mechanisms of aging and the progression of complex age-related diseases. Multiple biological layers—including the genome, transcriptome, proteome, and metabolome—interact dynamically during aging to regulate and carry out biological functions. Scientists are increasingly relying on multi-omics approaches to uncover biomarkers, pathways, and therapeutic targets associated with aging and age-related diseases.
The multi-omics analysis services at CD BioSciences can provide an all-inclusive package, from the experiment design and data generation, to the in-depth bioinformatics analysis, allowing scientists to unravel intricate interactions that contribute to aging processes. Given that it's difficult for single omics to provide a comprehensive understanding of the biological mechanisms of aging and disease, at CD BioSciences, multiple omics approaches (e.g., genomics, transcriptomics, proteomics, immunomics, metabolomics, epigenomics, single-cell omics, and spatial omics) are integrated to cover various biological information at different scales including genetic variations, gene expression patterns, protein abundance, metabolite profiles, epigenetic modifications, and so on! Based on the multi-omics aging biomarker services, CD BioSciences have discovered sets of biomarkers related to aging. Such biomarkers might be indicative for biological age and therefore be of great interest to reveal the course of aging.
To better understand the molecular mechanisms of aging, CD BioSciences also offers a comprehensive range of multi-omics aging clock development solutions. These clocks will provide a quantitative measure of biological age, offer insights into the underlying molecular processes associated with aging, and assist in the discovery and development of novel therapeutics targeting age-related diseases.
CD BioSciences' multi-omics analysis services are particularly valuable for academic institutions, pharmaceutical companies, and biotech firms focused on geroscience, longevity research, and precision medicine. By integrating multi-omics data, researchers can identify potential therapeutic targets, validate aging biomarkers, and develop predictive models for aging trajectories.
About CD BioSciences
CD BioSciences is a research service provider specializing in aging research. It offers a comprehensive range of services, encompassing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products. With a team of experienced scientists and advanced facilities, CD BioSciences is committed to advancing the understanding of aging and developing innovative solutions to promote healthy aging.
Follow Us on: Facebook | Twitter | LinkedIn
Media Contact
Company Name: CD BioSciences
Contact Person: Kikiwi Davis
Email: Send Email
Phone: 1-315-636-4280
Country: United States
Website: https://www.agingclocks.com
